ID   CM-1 [Human/mouse hybridoma]
AC   CVCL_XI18
SY   CM-I
DR   Wikidata; Q93455192
RX   Patent=WO2009104100A2;
RX   PubMed=12775891;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2584.
CC   Monoclonal antibody isotype: IgM, lambda.
CC   Monoclonal antibody target: Human cancer cells.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9V19 ! HAB-1
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
RX   Patent=WO2009104100A2;
RA   Vollmers H.P., Hensel F., Power B.E., Ilag L.L., Kelter A.-R.,
RA   Schoenen F., Muller-Hermelink H.-K., Thalheimer A., Udabage L.,
RA   Brandlein S.U.;
RT   "Antibody combinations, and methods of making and using same.";
RL   Patent number WO2009104100A2, 27-Aug-2009.
//
RX   PubMed=12775891; DOI=10.3233/HAB-2002-11401;
RA   Brandlein S.U., Lorenz J., Ruoff N., Hensel F., Beyer I., Muller J.,
RA   Neukam K., Illert B., Eck M., Muller-Hermelink H.-K., Vollmers H.P.;
RT   "Human monoclonal IgM antibodies with apoptotic activity isolated from
RT   cancer patients.";
RL   Hum. Antibodies 11:107-119(2002).
//